Short-term adherence to migraine prophylaxis is poor, with about one-half of patients stopping their medication within a year, according to the results of a systematic review (Hepp et al. J Manag Care Pharm 2014;20:22-33).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
